Preliminary Results for Period 1st July 2016 to 31st December 2016
Based on Unaudited Financial Accounts
- Operating revenue of $80 mill (up 3% or $2.6 mill on 1HFY16)
- Core radiology EBITDA expected to be $9.3 mill before one-off restructuring costs, ahead
of guidance of $7.9 mill- Full year results guidance: Group Operating Revenue of $162 mill to $165 mill and Core
Radiology EBITDA of $19.5 mill to $21.5 mill (before one-off / restructuring costs)- Sound progress on actions to deleverage balance sheet, reduce overheads, and
consolidate or sell underperforming sites- Second Quarter growth in Medicare DI receipts continued a trend toward longer term
growth levels
Capitol Health Limited (ASX:CAJ) (“Capitol” or the “Company”) provides preliminary unaudited half year results for the period 1 July 2016 through 31 December 2016, along with revenue and earnings guidance for the full year to 30 June 2017.
- Forums
- ASX - By Stock
- CAJ
- Ann: Preliminary Unaudited Half Year Results
Ann: Preliminary Unaudited Half Year Results, page-3
Featured News
Add CAJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
0.005(1.30%) |
Mkt cap ! $416.0M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 38.0¢ | $209.2K | 542.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 173127 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 1692743 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 173127 | 0.380 |
1 | 100000 | 0.375 |
5 | 138201 | 0.360 |
1 | 8550 | 0.350 |
1 | 16260 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 1692743 | 25 |
0.395 | 1227061 | 5 |
0.400 | 2382103 | 8 |
0.405 | 40050 | 1 |
0.410 | 127390 | 3 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
CAJ (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online